According to the Oncomine online database, the downregulation of SFTPA1 expression was observed in the brain and central nervous system cancer, breast cancer, and lung cancer, whereas it was up-regulated in prostate cancer (Supplementary Fig. 1c). Here, SFTPA1 is linked to prostate cancer.